News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GenVault Corporation to Present at the 2009 BIOCOM Investor Conference


10/23/2009 11:31:11 AM

CARLSBAD, Calif., Oct. 23 /PRNewswire/ -- GenVault Corporation, the leader in ambient temperature biosample management for genomic discovery, medicine and identification, today announced that David Wellis, Ph.D., GenVault's President and CEO, will be presenting at the BIOCOM Investor Conference taking place on October 26th and 27th in La Jolla, CA.

During the presentation, Dr. Wellis will provide an overview of the company together with recent customer, technical and strategic developments that have enabled GenVault to target the broader life sciences transport and storage markets. The major advantages of GenVault's technologies are the reduction of cost, waste and complexity associated with traditional biosample management in the academic and commercial sectors of the life sciences marketplace.

The following are specific details of GenVault's presentation at the conference:

BIOCOM Investor Conference

Date: Monday, October 26th, 2009

Time: 4:00pm (Track 2)

Location: Hyatt Regency La Jolla

Room: Aventine Ballroom, Room B

About GenVault

GenVault is the global leader in providing risk free biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable, reliable and environmentally friendly alternative to traditional freezers and DNA purification systems, the company's dry-state platform enables the extraction, preservation, recovery, and distribution of biosamples at ambient temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlates to the Dynamic Archive, GenVault is continuously developing and refining best practices biosample management and preservation. For more information visit GenVault at www.genvault.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Bret Dash

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87941

SOURCE GenVault Corporation

CONTACT: Bret Dash, Director of Marketing of GenVault Corporation,
+1-760-717-3774, bdash@genvault.com

Web site: http://www.genvault.com/


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES